Abstract:The pharmaceutical industry requires a highly qualified workforce with diverse skillsets. Medical affairs pharmaceutical physicians (MAPPs) have unique qualifications among pharmaceutical company employees, but the exact contribution of their education and training is unknown. This study aimed to identify the medical education and training competencies MAPPs use in the pharmaceutical industry in relation to the four external stakeholders, regulators, payors, prescribers, and patients. Ten MAPPs were recruited using convenience sampling via professional networks. A systematic literature review and the Jandhyala method, a two-stage qualitative online consensus method, identified which of MAPPs' medical education and training competencies they used in their work with each external stakeholder. Statistical analyses determined heterogeneity in the relevance of competencies and competency categories to each stakeholder. Nine MAPPs completed the study. Of the 59 competencies identified, 54 were relevant to all external stakeholders. Relevance of competencies varied significantly between external stakeholders ( p = .0434). Binary competency scores varied significantly for three pairs of stakeholders, "patient vs. payor" ( p = .025), "prescriber vs. regulator" ( p = .013) and "prescriber vs. payor" ( p = .008). Between-stakeholder overall frequency count varied significantly for two of the nine competency categories. MAPPs develop a highly specialized set of competencies during medical education and training from which they use distinct subsets to meet the needs of external stakeholders in the pharmaceutical industry. Undergraduate and postgraduate competency-based medical education appears to prepare MAPPs for cognitive and technical work. Further exploration may aid understanding of how they develop soft skills. Medical affairs pharmaceutical physicians (MAPPs) are of key importance in promoting patient centricity in the pharmaceutical industry. Their competency-based medical education and clinical experience give them a unique skillset among pharmaceutical company employees. MAPPs utilize their training to benefit pharmaceutical companies as well as the four external stakeholders in medicine adoption: regulators, payors, prescribers and patients. Previous work has suggested that their education and training may account for their ability to benefit all external stakeholders; however, this has not been explored in detail. The aim of this study was to identify competencies MAPPs develop during medical education, training and clinical experience and which of these they use in their work with each of the four external stakeholders. To do this, first, we reviewed the literature and asked MAPPs to self-report the competencies they developed during medical education and training, and which were relevant to their work with each of the four stakeholders. We found that 54 of the 59 identified competencies were relevant to work with all external stakeholders. However, the relevance of individual competencies varied between external stakeholders, with further analysis showing that the difference appeared to be accounted for by differences between three main pairs of stakeholders. These were "patient vs. payor", "prescriber vs. regulator" and "prescriber vs. payor. In other words, MAPPs were likely to use different competencies in their work with each stakeholder. With our analysis of competency categories, we concluded that MAPPs use a highly specialized combination of competencies adapted to each external stakeholder.

Mapping Physicians' Experiences with Medicinal Products from Whole Medical Systems: A Descriptive Analysis of the Vademecum of Anthroposophic Medicines

Exploring the Use of Traditional Medicines, Natural Health Products and Conventional Medicines: Development and Testing of the New Zealand 'All-Medicines' Questionnaire

How does the role of complementary and alternative medicine in general practice differ between countries? Interviews with doctors who have worked both in Germany and elsewhere in Europe

"Quality profiling" for complementary medicine: the example of a hospital for traditional Chinese medicine

An In-Depth Analysis

Wellness or medicine? Use and perception of Ayurveda in Germany: data from an online-representative cross-sectional study

Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings

Use of complementary medicine products: a nationally representative cross-sectional survey of 2019 Australian adults

Opinions on Kampo and reasons for using it--results from a cross-sectional survey in three Japanese clinics

[How Common are Complementary Medicine Procedures in Bavarian Acute Care Hospitals? Results of A Bavarian-wide Website Screening]

Saxon Epidemiological Study in General Practice-6 (SESAM-6): protocol of a cross-sectional study

Europe's Largest Research Infrastructure for Curated Medical Data Models with Semantic Annotations

Consensus Statement on the Outcome of the European Herbal Health Products Summit – Which Way Forward?

The rise of Traditional Chinese Medicine and its materia medica : a comparison of frequency and safety of materials and species used in Europe and China

Conserving traditional wisdom in a commodified landscape: Unpacking brand Ayurveda

Use and acceptance of traditional, complementary and integrative medicine in Germany—an online representative cross-sectional study

[Medical students and alternative medicine--a survey]

Somatoform Disorders in Primary Care-An Exploratory Mixed-Methods Study on Experiences, Challenges and Coping Strategies of General Practitioners in the Federal Republic of Germany

[Outpatient medical specialist care (ASV): A multiperspective study on status quo, challenges and perspectives]

Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method

The Implementation of an Electronic Medical Record in a German Hospital and the Change in Completeness of Documentation: Longitudinal Document Analysis